期刊文献+

血清CA125水平变化在肝硬化患者中的临床意义 被引量:1

下载PDF
导出
摘要 目的探讨血清CA125水平变化在肝硬化患者中的临床意义。方法肝硬化住院患者105例,根据Child-pugh积分法分A级28例,B级40例,C级37例,设慢性胃炎及健康体检者为对照组48例。肝硬化患者治疗前后静脉采血,分离血清,采用电化学发光法检测血清CA125水平。结果肝硬化患者血清CA125水平显著高于对照组,P<0.01。血清CA125水平随着肝功能损害程度的加重而升高,B级较A级及C级较B级均显著升高,P<0.05;经常规护肝治疗后,A级及B级显著下降,P<0.05,C级治疗前后无显著差异,P>0.05。结论肝硬化患者血清CA125水平升高及升高程度与肝功能损害程度密切相关,其水平可作为反映肝功能损害程度的指标之一,并可能成为监测肝硬化患者腹水消长的一项有用指标。
出处 《华夏医学》 CAS 2006年第6期1121-1122,共2页 Acta Medicinae Sinica
  • 相关文献

参考文献5

二级参考文献22

  • 1陈灏珠.实用内科学[M](第11版)[M].北京:人民卫生出版社,2002.1971-1973.
  • 2Molina R, Filella J, Mengual P, Bosch J, et al. Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases [J]. Clin Chem, 1991, 37 (8): 1379~83.
  • 3Zuckerman E, Lanir A, Sabo E, Sabo E, et al. Cancer antigen 125:a sensitive marker of ascites in patients with liver cirrhosis [J] . Am J Gastroenterol, 1999, 94 (6): 1613~8.
  • 4Devarbhavi H, Kaese D, Williams AW, et al. Cancer antigen 125 in patients with chronic liver disease [J]. Mayo Clin Proc 2002, 77(6): 538~41.
  • 5WHITEHOUSE C, SOLOMON E. Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening[J]. Gynecol Oncol,2003,88(1Pt 2):S152-157.
  • 6GUPPY A E,RUSTIN G J. CA125 response: can it replace the traditional response criteria in ovarian cancer-[J]. Oncologist, 2002,7(5):437-443.
  • 7TSUDA H, HASHIGUCHI Y, NAKATA S, et al. The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer[J]. Int J Gynecol Cancer, 2002,12(5):435-437.
  • 8SIMSEK H, KADAYIFCI A, OKAN E. Importance of serum CA125 levels in malignant peritoneal mesothelioma[J]. Tumour Biol, 1996,17(1):1-4.
  • 9TOPALAK O, SAYGILI U, SOYTURK M, et al. Serum, pleural effusion, and ascites CA125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study[J]. Gynecol Oncol,2002,85(1):108-113.
  • 10MAVLIGIT G M, ESTROV Z. CA125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen[J]. Am J Clin Oncol, 2000,23(2):213-215.

共引文献22

同被引文献4

  • 1Kalantri Y,Naik G,Joshi SP,et al.Role of cancer antigen-125 from pleural & ascitic fluid samples in non malignant conditions[J].Indian J Med Res,2007,125(1):25-30.
  • 2Kemer T,Ormen M,Kuralay F,et al.Diagnostic usefulness of carbohydrate antigen-125 in cancerous and noncancerous peritoneal effusions[J].Tohoku J Exp Med,2005,205(1):l 1-18.
  • 3Kalambokis G,Kostoula A,Economou M,et al.Tumor necrosis factor- alpha-related intraperitoneal release of CA 125 in cirrhotic patients with sterile ascites[J].Clin Chem,2005,51(11):2207-2208.
  • 4Leggio L,Abenavoli L,D'Angelo C,et al.Marked decrease of serum Ca 125 levels after Denver shunt placement in a patient with cirrhosis and refractory ascites[J].Dig Dis Sci,2006,51 (9): 1644-1646.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部